The MDM System offers the most extensive test panel of many microbial metabolites, far more than any other lab. Approximately 85% of children with autism have an average of 3 microbial metabolites at levels far above any typically-developing child.
Order the MDM System Test to determine if you or your child has a bacterial or yeast infection that is affecting their gut or brain health. The results will help guide you and your physician to the appropriate treatment path for fungal and/or bacterial therapies.
Our patented Microbial-Derived Metabolite (MDM™) system uses a simple urine sample to deliver unmatched diagnostic clarity
This non-invasive approach makes testing more accessible—especially for children with sensory sensitivities or behavioral challenges
Unlike competing tests, our solution offers:
Our MDM test has achieved unmatched specificity, meaning zero false positives—a critical standard for meaningful diagnosis.
Our precision (>90%) metabolomics approach detects unique microbial and metabolic markers commonly elevated in children with autism, outperforming current commercial alternatives.
Our report includes actionable suggestions that support targeted interventions, enabling clinicians and families to make personalized treatment decisions.
We go beyond detecting risk of autism: our test provides insights into underlying biological imbalances—including gut microbial disruptions—that may contribute to ASD symptoms.
Most available tests lack accuracy, provide no insight into root causes, and offer no direction for next steps—leaving families with more questions than answers.
CLIA-certified, HIPAA-compliant genomic testing designed for clinicians, families, and researchers — delivered with clarity, speed, and compassion.
